Programs

To tackle the human health challenges that face the world today, the FNIH develops collaborations with top experts from government, industry, academia and the not-for-profit sector and provides a neutral environment where we can work productively toward a common goal.

2019 NIH GSIG Geroscience Summit

The National Institutes of Health Geroscience Interest Group is hosting a two-day Summit to bring together leading researchers, innovators and public advocates from academia, industry, the non-profit sector and the NIH to discuss geroscience concepts and potential opportunities to advance research on chronic diseases that incorporate principles of geroscience.

The Science of Caregiving, Bringing Voices Together

The National Institute of Nursing Research hosted a two-day Summit to gather a variety of stakeholder perspectives on the spectrum of caregiving issues and research for conditions and illnesses that may occur across the lifespan.

Cognitive Aging Summit III

Cognitive Aging Summit III will bring together experts in a variety of research fields to discuss the most cutting edge advances in our understanding of age-related brain and cognitive changes, with a particular focus on resilience and reserve.

Stephen J. Solarz Memorial Fund

The Stephen J. Solarz Memorial Fund supports immunotherapy research in the laboratory of David Schrump, M.D. at the Center for Cancer Research of the National Cancer Institute (NCI). Funds are used to provide international fellowship opportunities to aspiring post-doctorate scientists and researchers in the field of cancer.

Dr. Anita Roberts Memorial Fund

The Dr. Anita Roberts Memorial Fund awards travel scholarships for graduate students and post-doctoral fellows to present their work at a national meeting.

Go4Life

Go4Life is a signature public health campaign by the National Institute on Aging (NIA) to encourage older adults to get active and stay active.

Biomarkers Consortium – CSC Scientific Symposium

The Cancer Steering Committee (CSC) Scientific Symposium reviews advances in the field of biomarker and regulatory science that are relevant to the development of new public-private partnerships for precompetitive biomarkers. This review assists the CSC with planning future public- private partnerships in this area.